1. Home
  2. UPBD vs EVO Comparison

UPBD vs EVO Comparison

Compare UPBD & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$19.91

Market Cap

1.1B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.76

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPBD
EVO
Founded
1986
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
994.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UPBD
EVO
Price
$19.91
$2.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$32.25
$7.00
AVG Volume (30 Days)
862.8K
29.4K
Earning Date
04-30-2026
04-08-2026
Dividend Yield
8.25%
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$4,695,061,000.00
N/A
Revenue This Year
$5.96
$1.37
Revenue Next Year
$6.47
$10.05
P/E Ratio
$32.52
N/A
Revenue Growth
8.67
N/A
52 Week Low
$15.82
$2.31
52 Week High
$28.03
$4.42

Technical Indicators

Market Signals
Indicator
UPBD
EVO
Relative Strength Index (RSI) 61.42 48.27
Support Level $17.17 $2.60
Resistance Level $20.99 $3.82
Average True Range (ATR) 0.86 0.07
MACD 0.17 0.00
Stochastic Oscillator 86.13 66.07

Price Performance

Historical Comparison
UPBD
EVO

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: